CD56 expression in acute promyelocytic leukemia : A possible indicator of poor treatment outcome?MURRAY, C. K; ESTEY, E; PAIETTA, E et al.Journal of clinical oncology. 1999, Vol 17, Num 1, pp 293-297, issn 0732-183XArticle

Role of plasminogen activator inhibitor-1 in promoting fibrin deposition in rabbits infused with ancrod or thrombinCHITRA KRISHNAMURTI; BOLAN, C; COLLETON, C. A et al.Blood. 1993, Vol 82, Num 12, pp 3631-3636, issn 0006-4971Article

Pharmacologic agents in the management of bleeding disordersBOLAN, C. D; ALVING, B. M.Transfusion (Philadelphia, PA). 1990, Vol 30, Num 6, pp 541-551, issn 0041-1132Article

Hemolytic anemia and cancerDIEHL, L. F; BOLAN, C. D; WEISS, R. B et al.Cancer treatment reviews. 1996, Vol 22, Num 1, pp 33-73, issn 0305-7372Article

Association of protein S deficiency with thrombosis in a kindred with increased levels of plasminogen activator inhibitor-1BOLAN, C. D; KRISHNAMURTI, C; TANG, D. B et al.Annals of internal medicine. 1993, Vol 119, Num 8, pp 779-785, issn 0003-4819Article

Synchronous diffuse well-differentiated lymphocytic lymphoma and gastric adenocarcinoma presenting as splenomegaly and iron deficiency anemiaFINK, L. M; BOLAN, C. D; KRISHNAN, J et al.The American journal of gastroenterology. 1990, Vol 85, Num 12, pp 1635-1636, issn 0002-9270, 2 p.Article

Persistence of recipient plasma cells and anti-donor isohaemagglutinins in patients with delayed donor erythropoiesis after major ABO incompatible non-myeloablative haematopoietic cell transplantationGRIFFITH, L. M; MCCOY, J. P; BOLAN, C. D et al.British journal of haematology. 2005, Vol 128, Num 5, pp 668-675, issn 0007-1048, 8 p.Article